Markets & Economy Teva’s (TEVA) $125 Million BioXcel Bid Offers Upside, but FDA and Auction Risks Remain September 12, 2026 · 4:57 pm 1 sources Image: Yahoo Finance ad slot · in-content video 16:9 Coverage More coverageTeva’s (TEVA) $125 Million BioXcel Bid Offers Upside, but FDA and Auction Risks RemainYahoo Finance · September 12, 2026 16:57
